For example, Wang et al. demonstrated that treatment of ovarian cancer cells with the TRPV1 antagonist, DWP05195, increased ROS production via NOX upregulation; increased ROS upregulated CHOP activity leading to ER stress-mediated apoptosis. This evidence concerns the gene DDIT3 and ovarian carcinoma.